• 1 for 4 non-renounceable pro rata entitlement offer to raise up to $4.1 million
• Proceeds to fund device manufacturing, marketing, supply chain, R&D, and debt repayment
• Offer fully underwritten by Blackpeak Capital, with C2 Ventures and Carnethy Evergreen as sub-underwriters

Cardiex Ltd is pleased to invite eligible shareholders to participate in a 1 for 4 non-renounceable pro rata entitlement offer to raise up to approximately $4.1 million (before costs). The offer provides shareholders the opportunity to further invest in the company as it continues to advance its plans regarding device manufacturing and supply chain scale-up. The entitlement offer is being undertaken in conjunction with a $2.4 million placement, with the proceeds to be used for device manufacturing, marketing and sales activities, supply chain scale-up, further R&D, debt repayment, and corporate/working capital. The entitlement offer is fully underwritten by Blackpeak Capital, with C2 Ventures Pty Limited and Carnethy Evergreen Pty Ltd (a company controlled by director Niall Cairns) acting as sub-underwriters for up to $1.2 million of the underwriting commitment. Eligible shareholders can take up their entitlement in full or in part, or do nothing in which case their entitlement will lapse. Those who take up their full entitlement can also apply for additional 'top-up' shares subject to availability.